FindMyKOL
Clinical trialNCT00019110CompletedPhase 1Interventional

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

SponsorNational Cancer Institute (NCI)Anal CancerCervical CancerEsophageal CancerHead and Neck CancerPenile CancerVulvar Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Vaccines made from certain human papillomaviruses may be able to help the body to kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of human papillomavirus vaccine therapy in treating patients who have advanced or recurrent cancer of the cervix, vagina, penis, anus, esophagus, or head and neck.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Center for Cancer Research

    Bethesda, Maryland, United States

  • Warren Grant Magnuson Clinical Center - Nci Clinical Studies Support

    Bethesda, Maryland, United States

  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, United States

  • Morristown Memorial Hospital

    Morristown, New Jersey, United States

  • University of Texas Medical Branch

    Galveston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Human papillomavirus 16 E7 peptideSynthetic human papillomavirus 16 E6 peptide
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 1995
Primary completion
—
Completion
—
Last update posted
29 Apr 2015
Registered enrollment
—
Registry id
NCT00019110
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.